Search results for "K-Pharma"

“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

The first domestically developed obesity medication is entering South Korea’s weight-loss market, long dominated by foreign pharmaceuticals such as...
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug

Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug

A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported products such as Wegovy and Mounjaro.
Dongkook Pharmaceutical’s Madeca Pharmacia Expands to Hyundai Department Store’s ‘Khōde’

Dongkook Pharmaceutical’s Madeca Pharmacia Expands to Hyundai Department Store’s ‘Khōde’

Dongkook Pharmaceutical announced on October 7 that its derma repair brand, Madeca Pharmacia, has launched at Khōde, a...

"Throw These Out Today": Pharmacist Warns Against 5 Common Kitchen Items That Pose Hidden Health Risks

The traditional maxim that frugality is always a virtue does not always apply in the kitchen.
Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup

Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup

Sore-throat spray "Mok-Anne" and artificial tear formula "Nun-Anne"—two familiar over-the-counter products in South...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
South Korea Bans Pharmacies From Using 'Warehouse' or 'Factory' on Signage

South Korea Bans Pharmacies From Using 'Warehouse' or 'Factory' on Signage

Pharmacies in South Korea will no longer be allowed to use terms that evoke a “warehouse” or “factory” on their...
Yuhan Expands Antiphlamine Initiative into Nationwide Veterans Support Pact Ahead of 100th Anniversary

Yuhan Expands Antiphlamine Initiative into Nationwide Veterans Support Pact Ahead of 100th Anniversary

Nine years into the program, the cumulative total of the "Patriotism Antiphlamine Sharing Box" delivered by Yuhan...